Effectiveness of highly active antiretroviral therapy (HAART) used concomitantly with rifampicin in patients with tuberculosis and AIDS
Autor: | Valeria Cavalcanti Rolla, Luciane de Souza Velasque, Flavia Marinho Sant’Anna, M. J. M. Costa, Beatriz Grinsztejn, Mariza G. Morgado, Carolina Arana Stanis Schmaltz, Maria C.S. Lourenço |
---|---|
Jazyk: | angličtina |
Předmět: |
Adult
Male Microbiology (medical) medicine.medical_specialty Efavirenz Tuberculosis HAART Anti-HIV Agents Antitubercular Agents lcsh:QR1-502 effectiveness HIV Infections rifampicin lcsh:Microbiology lcsh:Infectious and parasitic diseases Young Adult chemistry.chemical_compound immune system diseases Antiretroviral Therapy Highly Active Internal medicine medicine Humans lcsh:RC109-216 business.industry virus diseases Middle Aged Viral Load medicine.disease CD4 Lymphocyte Count AIDS Regimen Treatment Outcome Infectious Diseases chemistry Tolerability Concomitant Immunology Female Ritonavir Rifampin business Saquinavir Rifampicin Follow-Up Studies medicine.drug |
Zdroj: | Brazilian Journal of Infectious Diseases, Vol 13, Iss 5, Pp 362-366 Brazilian Journal of Infectious Diseases v.13 n.5 2009 Brazilian Journal of Infectious Diseases Brazilian Society of Infectious Diseases (BSID) instacron:BSID Brazilian Journal of Infectious Diseases, Volume: 13, Issue: 5, Pages: 362-366, Published: OCT 2009 |
ISSN: | 1678-4391 |
Popis: | This study evaluated the effectiveness of two HAART regimens concomitant to rifampicin based tuberculosis (TB) treatment. Patients with TB/HIV diagnosis followed at the TB program between June 2000 and March 2005 were prospectively evaluated. The different HAART regimens in antiretrovirals (ARV) treatment naïve and ARV experienced patients were compared. The effectiveness of HAART was defined as a VL |
Databáze: | OpenAIRE |
Externí odkaz: |